What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?

European Journal of Gastroenterology and Hepatology, Supplement

Volumn 12, Issue 1, 2000, Pages

  Hawkey, Christopher J ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Nonsteroidal anti inflammatory drugs; Peptic ulcers; Prophylaxis

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROTON PUMP INHIBITOR;

ARTHRITIS; DUODENUM ULCER; ERADICATION THERAPY; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; REVIEW; STOMACH MUCOSA; STOMACH ULCER; ULCER HEALING;

EID: 0033894892     PISSN: 09699163     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012061-00005     Document Type: Review

References (20)

1. Cullen DJ, Hawkey GM, Greenwood DC, Humphreys H, Shepherd V, Logan RF, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997; 41:459-462.
2. Labenz J, Peitz U, Kohl H, Kaiser J, Malfertheiner P, Hackelsberger A, et al. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study. Ital J Gastroenterol Hepatol 1999; 31:110-115.
3. Stack WA, Hawkey GM, Atherton JC, Logan RF, Hawkey CJ. Interaction of risk factors for peptic ulcer bleeding [abstract]. Gastroenterology 1999; 116:A97.
4. Wu CY, Poon SK, Chen GH, Chang CS, Yen HZ. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding. Scand J Gastroenterol 1999; 34:234-237.
5. Aalykke A, Lauritsen JM, Hallas J, Reinholdt S, Krogfeldt K, Lauritsen K. Helicobacter pylori and risk of ulcer bleeding among users of non-steroidal anti-inflammatory drugs: a case control study. Gastroenterology 1999; 116:1305-1309.
6. Lanas A. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding. Ital J Gastroenterol Hepatol 1999; 31(suppl 1):S37-S42.
7. Chan FKL, Sung JY, Chung SCS, To KF, Yung MY, Leung VK, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350:975-979.
8. Hawkey CJ, Tulassay Z, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, Wason CM, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998; 352:1016-1021.
9. Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer heating and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut 1996; 39:22-26.
10. Yanaka A, Nakahara A, Tanaka N, Muto H. Eradication of Helicobacter pylori does not prevent ulcer relapse in patients with NSAID-induced gastric ulcer [abstract]. Gastroenterology 1999; 116:A362.
11. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW. Aspirin use and risk of fatal cancer. Cancer Res 1993; 53:1322-1327.
12. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85:307-311.
13. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 38:727-734.
14. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338:719-726.
15. Agrawal N, Safdi M, Wruble L, Karvois D, Greski-Rose P. Effectiveness of lansoprazole in the healing of NSAID-induced gastric ulcer in patients continuing to take NSAIDs [abstract]. Gastroenterology 1998; 114:G0213.
16. Hudson N, Taha AS, Russell RI, Trye P, Cottrell J, Mann SG, et al. Famotidine for healing and maintenance in non-steroidal anti-inflammatory drug associated gastroduodenal ulceration. Gastroenterology 1997; 112:1817-1822.
17. Labenz J, Tillenburg B, Peitz U, Verdu E, Stolte M, Borsch G, et al. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 1997; 41:33-36.
18. Labenz J, Tillenburg B, Peitz U, Idstrom JP, Verdu EF, Stolte M, et al. Helicobacter pylori augments the pH increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110:725-732.
19. Chan FKL, Sung JY, Suen R, Lee YT, Leung WK, Leung VKS, et al. Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users: a prospective randomised study [abstract]. Gastroenterology 1998; 114:A87.
20. Chan FKL, Sung JJY, Suen R, Lee YT, Wu JCY, Leung WK, et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomised study. Aliment Pharmacol Ther 1998; 12:1201-1205.